Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01934413 · ClinicalTrials.gov registry record · NA

Technology-enhanced Transitional Care for Rural Palliative Care Patients: A Pilot Study

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
17
Enrollment target

NCT01934413: Completed NA study, sponsored by Mayo Clinic.

NCT01934413 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01934413, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
17 participants
Enrollment target

Study Summary

The purpose of this pilot study is to develop and test a technology-enhanced transitional palliative care (TPC) intervention for patients and caregivers living in rural locations. The investigators hypothesize that access to palliative care will be improved, thereby improving patient and caregiver reported outcomes and decreasing the use of costly health services.

Primary Outcome

The patient's quality of life will be determined by the change in mean scores from baseline to 1 month and 2 months post enrollment, using the Functional Assessment of Chronic Illness Therapy - Palliative Care Scale (FACIT-Pal). The FACIT-Pal palliative subscale contains 19 questions specific to persons with life-limiting illness. Each item is rated on a 5 point numeric rating scale from 9 (not at all) to 4 (very much). Scores range from 0-76. Higher scores indicate better quality of life.

Interventions

  • OTHER Usual Standard of Care
  • BEHAVIORAL Technology-Enhanced Transitional Palliative Care

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2013-09
Est. Completion 2015-02
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT01934413 record still lists

NCT01934413 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Usual Standard of Care is the first listed.

NCT01934413 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01934413 about?

NCT01934413 is a clinical study titled "Technology-enhanced Transitional Care for Rural Palliative Care Patients: A Pilot Study". The purpose of this pilot study is to develop and test a technology-enhanced transitional palliative care (TPC) intervention for patients and caregivers living in rural locations. The investigators hypothesize that access to palliative care will be improved, thereby improving patient and caregiver r...

What is the current status of trial NCT01934413?

This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2013-09. Estimated completion is 2015-02.

What interventions are being tested in trial NCT01934413?

The interventions under investigation include: Usual Standard of Care (OTHER), Technology-Enhanced Transitional Palliative Care (BEHAVIORAL).

Who is sponsoring clinical trial NCT01934413?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01934413's enrollment target sits among peer trials

17 1871st of 2000 higher than 130 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02090140 · 17 participants · NA

    Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects

  • NCT03317860 · 17 participants · NA

    Improving Measurement and Treatment of Post-stroke Neglect

  • NCT04356469 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

  • NCT04414046 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01934413, the US trial registry maintained by the National Library of Medicine. NCT01934413 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.